Showing 1 - 10 of 16
Persistent link: https://www.econbiz.de/10011477734
Persistent link: https://www.econbiz.de/10009404219
The pharmaceutical industry is a textbook example of a science based sector characterized by high R&D cost, uncertain and spillovers for which patent protection assures appropriability thus providing incentives for innovation. Indeed, Mansfield (1986) found that, absent patent protection, 60...
Persistent link: https://www.econbiz.de/10014216850
This paper investigates patterns of industrial dynamics and competition in the pharmaceutical industry, with particular reference to the consequences of patent expiry in different countries. We focus on the competition at the level of single chemical entities, distinguishing between original...
Persistent link: https://www.econbiz.de/10014048098
This paper investigates patterns of industrial dynamics and competition in the pharmaceutical industry, with particular reference to the consequences of patent expiry in different countries. We focus on the competition at the level of single chemical entities, distinguishing between original...
Persistent link: https://www.econbiz.de/10005034975
Persistent link: https://www.econbiz.de/10003449162
Persistent link: https://www.econbiz.de/10001740650
Persistent link: https://www.econbiz.de/10001904812
An explosion of knowledge and a growing array of tools and technologies have transformed modern drug Ramp;D, while its cost has risen by a sizable amount. At the same time, the unchecked increase in health care and prescription drug spending has spawned cost containment policies that are...
Persistent link: https://www.econbiz.de/10012751737
Persistent link: https://www.econbiz.de/10013179155